| Literature DB >> 29382138 |
Dae Young Lee1, Hyoung-Geun Kim2, Yeong-Geun Lee3, Jin Hee Kim4, Jae Won Lee5, Bo-Ram Choi6, In-Bae Jang7, Geum-Soog Kim8, Nam-In Baek9.
Abstract
A new ginsenoside, named ginsenoside Rh23 (1), and 20-O-β-d-glucopyranosyl-3β,6α,12β,20β,25-pentahydroxydammar-23-ene (2) were isolated from the leaves of hydroponic Panax ginseng. Compounds were isolated by various column chromatography and their structures were determined based on spectroscopic methods, including high resolution quadrupole/time of flight mass spectrometry (HR-QTOF/MS), nuclear magnetic resonance (NMR) spectroscopy, and infrared (IR) spectroscopy. To determine anti-melanogenic activity, the change in the melanin content in melan-a cells treated with identified compounds was tested. Additionally, we investigated the melanin inhibitory effects of ginsenoside Rh23 on pigmentation in a zebrafish in vivo model. Compound 1 inhibited potent melanogenesis in melan-a cells with 37.0% melanogenesis inhibition at 80 µM and also presented inhibition on the body pigmentation in zebrafish model. Although compound 2 showed slightly lower inhibitory activity than compound 1, it also showed significantly decreased melanogenesis in melan-a cell and in zebrafish model. These results indicated that compounds isolated from hydroponic P. ginseng may be used as new skin whitening compound through the in vitro and in vivo systems. Furthermore, this study demonstrated the utility of MS-based compound 1 for the quantitative analysis. Ginsenoside Rh23 (1) was found at a level of 0.31 mg/g in leaves of hydroponic P. ginseng.Entities:
Keywords: NMR; Panax ginseng; UPLC-QTOF/MS; ginsenoside Rh23; quantitative analysis; zebrafish
Mesh:
Substances:
Year: 2018 PMID: 29382138 PMCID: PMC6017343 DOI: 10.3390/molecules23020267
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
1H- (400 MHz) and 13C-NMR (100 MHz) spectra of compounds 1 and 2 (in pyridine-d5).
| Compound 1 | Compound 2 | |||
|---|---|---|---|---|
| No. | δH in ppm, | δC | δH in ppm, | δC |
| 1 | 1.73, 1.02 | 39.4 | 1.70, 1.00 | 39.5 |
| 2 | 1.84, 1.83 | 28.1 | 1.83, 1.81 | 28.1 |
| 3 | 3.49 (1H, dd, | 78.5 | 3.50 (1H, dd, | 78.5 |
| 4 | - | 40.3 | - | 40.3 |
| 5 | 1.21 (1H, d, | 61.8 | 1.20 (1H, d, | 61.8 |
| 6 | 4.38 (1H, m) | 67.7 | 4.37 (1H, m) | 67.7 |
| 7 | 1.92, 1.87 | 47.4 | 1.91, 1.86 | 47.4 |
| 8 | - | 41.2 | - | 41.2 |
| 9 | 1.54 | 49.3 | 1.53 | 49.8 |
| 10 | - | 39.4 | - | 39.3 |
| 11 | 2.11, 1.58 | 31.0 | 2.08, 1.53 | 31.0 |
| 12 | 4.03 (1H, m) | 70.3 | 4.03 (1H, m) | 70.4 |
| 13 | 1.97 (1H, m) | 49.3 | 1.97 (1H, m) | 49.2 |
| 14 | - | 51.4 | - | 51.4 |
| 15 | 1.61, 0.99 | 30.7 | 1.57, 0.99 | 30.6 |
| 16 | 1.74, 1.40 | 26.4 | 1.72, 1.41 | 26.4 |
| 17 | 2.45 (1H, m) | 52.1 | 2.40 (1H, m) | 52.4 |
| 18 | 1.14 (3H, s) | 17.6 | 1.13 (3H, s) | 17.6 |
| 19 | 1.04 (3H, s) | 17.4 | 1.03 (3H, s) | 17.4 |
| 20 | - | 83.0 | - | 83.2 |
| 21 | 1.55 (3H, s) | 23.0 | 1.55 (3H, s) | 22.9 |
| 22 | 3.07 (1H, dd, | 39.6 | 3.01 (1H, dd, | 39.3 |
| 23 | 6.02 (1H, ddd, | 126.8 | 6.26 (1H, ddd, | 122.8 |
| 24 | 5.64 (1H, d, | 138.5 | 5.96 (1H, d, | 142.0 |
| 25 | - | 74.9 | - | 69.0 |
| 26 | 1.31 (3H, s) | 26.1 | 1.51 (3H, s) | 30.6 |
| 27 | 1.33 (3H, s) | 26.3 | 1.50 (3H, s) | 30.8 |
| 28 | 1.94 (3H, s) | 31.9 | 1.95 (3H, s) | 31.9 |
| 29 | 1.43 (3H, s) | 16.4 | 1.42 (3H, s) | 16.4 |
| 30 | 0.92 (3H, s) | 17.3 | 0.89 (3H, s) | 17.2 |
| OCH3 | 3.18 (3H, s) | 50.2 | - | - |
| 1′ | 5.15 (1H, d, | 98.3 | 5.15 (1H, d, | 98.4 |
| 2′ | 3.95 (1H, dd, | 75.2 | 3.94 (1H, dd, | 75.2 |
| 3′ | 4.18 (1H, dd, | 78.9 | 4.14 (1H, dd, | 78.9 |
| 4′ | 4.09 (1H, dd, | 71.6 | 4.07 (1H, dd, | 71.7 |
| 5′ | 3.90 (1H, ddd, | 78.2 | 3.90 (1H, ddd, | 78.2 |
| 6′ | 4.45 (1H, dd, | 63.0 | 4.46 (1H, dd, | 62.9 |
Figure 1Chemical structures of compounds 1 and 2, and key gHMBC (arrow) correlations of 1.
Figure 2TIC of HPGL extract and ginsenoside Rh23 by UPLC-QTOF/MS in negative-ion mode by selected ion monitoring, and representative QTOF/MS chromatograms
Linear regression data and contents of the validated method for the ginsenoside Rh23 in HPGL extract a.
| Compounds | Rt b (min) | Calibration Curve c | R2 | Line Arrange (µg/mL) | LOD d (ppm) | LOQ e (ppm) | Amount (mg/g) |
|---|---|---|---|---|---|---|---|
| Rh23 | 10.79 | 0.996 | 0.02–0.8 | 0.002 | 0.005 | 0.319 |
a Mean values of samples (n = 3). b Rt, retention time. c y, logarithmic value of peak area; x, logarithmic value of amount injected. d LOD, limit of detection. e LOQ, limit of quantification.
Figure 3Effects of compounds 1 and 2 on melanogenesis in melan-a cells. The cells were cultured with 0–80 µM of eight compound for four days. Inhibition of melanin synthesis was measured with triplicate experiments. Data are expressed a means ± SD of triplicate determinations. * p < 0.05, ** p < 0.01, *** p < 0.001 versus the control group.
Figure 4Effects of compound 1 on melanogenesis in zebrafish. Synchronized embryos were treated with melanogenic inhibitors at the indicated concentrations. Compound 1 was dissolved in 0.1% DMSO and then added to the embryo medium. The effects on pigmentation of zebrafish were observed under the stereomicroscope: (A) (vehicle control) untreated zebrafish embryo; (B) (positive control) 100 µM 1-phenyl-2-thiourea (PTU); (C) 40 µM compound 1; and (D) 80 µM compound 1.
Optimal conditions for the Q-TOF/MS analysis of HPGL extract.
| Optimal Q-TOF/MS Condition | |
|---|---|
| Ion Source | ESI Negative Mode |
| Source Temp. and Desolvation Temp. | 120 °C/550 °C |
| Cone Gas Flow and Desolvation Gas Flow | 30 L/h/800 L/h |
| Capillary Volt and Cone Volt | 3 k/40 V |
| Mass Range ( | 50 to 1000 |
| Collision Energy Range | 4 to 45 eV |